← SynDRA
CAMPTOTHECIN
SynDRA canonical compound SYN0000333 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
| Primary target(s) | TOP1 |
| Mechanism of action | Topoisomerase inhibitor |
All known targets
Mechanisms of action (all sources)
- topoisomerase inhibitor
- TOP1 MODULATOR
- TOP1 INHIBITOR
- DNA topoisomerase I inhibitor
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- HNRNPA1
- CHEK1
- HDAC6
- HTR2B
- ABCC4
- TOP2A
- NPY2R
- NFKB1
- NFE2L2
- MTOR
- MT-CO2
- MPHOSPH8
- MMP9
- MMP1
- MCL1
- MC5R
- MC4R
- MC3R
- MBNL1
- MAPK3
- MAPK14
- MAPK1
- MAOA
- LMNA
- LCK
- KDM4E
- KCNH2
- KAT2A
- HTT
- HTR6
- HTR2C
- TP53
- HTR2A
- HSD17B10
- TSHR
- HRH2
- NPY1R
- NR3C1
- THPO
- NR4A2
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- CP1A2
- SSTR1
- MITF
- NOD1
- NOD2
- NSD2
- NTM1A
- PARP1
- S1PR3
- SSTR2
- KLF5
- SSTR3
- SSTR4
- SSTR5
- SYK
- TFE3
- TNF
- TPO
- KSYK
- JAK2
- CP2CJ
- HDAC2
- CP3A4
- E2AK3
- ESRRA
- GPX4
- HDAC1
- HDAC10
- HDAC11
- HDAC3
- IFNG
- HDAC4
- HDAC5
- HDAC7
- HDAC8
- HDAC9
- HLAB
- IFNB1
- YAP1
Drug classes
- Antineoplastic Agents, Phytogenic
- Topoisomerase I Inhibitors
- anticancer agent
Cross-references
Synonyms
- Camptothecine
- Topotecan related compound c
- NSC-94600
- (S)-(+)-Camptothecin
- Campathecin
- d-Camptothecin
- (+)-Camptothecine
- (+)-Camptothecin
- 20(S)-Camptothecine
- 21,22-Secocamptothecin-21-oic acid lactone
- NSC94600
- (S)-Camptothecin
- Camptothecine (8CI)
- 20(S)-Camptothecin
- Camptothecine (S,+)
- CHEMBL65
- UNII-XT3Z54Z28A
- MLS000766223
- (4S)-4-ethyl-4-hydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
- XT3Z54Z28A
- CHEBI:27656
- VSJKWCGYPAHWDS-FQEVSTJZSA-N
- Camptothecin, Camptotheca acuminata
- Camptothecin derivat
- NSC 94600
- (S)-4-ethyl-4-hydroxy-1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
- MFCD00081076
- (19S)-19-ethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione
- NSC 100880
- (19S)-19-ethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.0^{2,11}.0^{4,9}.0^{15,20}]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione
- 1H-Pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione, 4-ethyl-4-hydroxy-, (4S)-
- 1H-Pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione, 4-ethyl-4-hydroxy-, (S)-
- 1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 4-ethyl-4-hydroxy-, (4S)-
- 4-ETHYL-4-HYDROXY-1,12-DIHYDRO-4H-2-OXA-6,12A-DIAZA-DIBENZO[B,H]FLUORENE-3,13-DIONE
- SR-01000075798
- SR-01000597379
- d-camptothecine
- (s)-camptothecine
Look up CAMPTOTHECIN in the interactive SynDRA portal →